Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1168 of 1,261
  1. US 6635764

    Therapeutic ureas

    Theravance, Inc. · Granted Oct 21, 2003 · Expires Oct 16, 2023

    expired
  2. US 6635672

    Agent for lowering prolactin

    Bionorica AG · Granted Oct 21, 2003 · Expires Oct 16, 2023

    expired
  3. US 6635644

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2003 · Expires Oct 16, 2023

    expired
  4. US 6635614

    Use of lecithin-cholesterol acyltransferase (LCAT) to reduce accumulation of cholesterol

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 21, 2003 · Expires Oct 16, 2023

    expired
  5. US 6635445

    Nucleic acid molecules encoding human luteinizing hormone-human chorionic gonadotropin receptor protein and transformants thereof

    Takeda Chemical Industries Ltd. · Granted Oct 21, 2003 · Expires Oct 16, 2023

    expired
  6. US 6635618

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Oct 21, 2003 · Expires Oct 16, 2023

    expired
  7. US 2003194376

    Ultrasound contrast agents and methods of making and using them

    BRACCO INT BV [US] · Granted Oct 16, 2003 · Expires Oct 11, 2023

    expired
  8. CA 2477935

    PRODUITS DE SYNTHESE MULTIVALENTS POUR APPLICATIONS THERAPEUTIQUES ET DIAGNOSTIQUES

    BRACCO INT BV [NL] · Granted Oct 16, 2003 · Expires Oct 11, 2023

    expired
  9. US 6632945

    Inhibitors of P38

    Vertex Pharmaceuticals Incorporated · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  10. US 6632789

    Methods for modulating T cell responses by manipulating intracellular signal transduction

    United States of America as represented by the Secretary of the Air Force · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  11. US 6632640

    Vaccine against Staphylococcus intoxication

    The United States of America as represented by the Secretary of the Army · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  12. US 6632446

    Coating substrates by polymerizing macromers having free radical-polymerizable substituents

    The Board of Regents of the University of Texas System · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  13. US 6632962

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  14. US 6632434

    Leptospiral major outer membrane protein, LipL 32

    The Regents of the University of California · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  15. US 6632809

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  16. US 6632808

    Inhibitors of amyloid formation

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  17. US 6632928

    Immunotoxins and methods of inducing immune tolerance

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  18. US 6632807

    (2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5- tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide

    Takeda Chemical Industries Ltd. · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  19. US 6632627

    Glutamine: fructose-6-phosphate amidotransferase, its production and use

    Takeda Chemical Industries Ltd. · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  20. US 6632626

    Methods of assaying farnesyl transferase

    The Board of Regents of the University of Texas System · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  21. US 6632441

    Mutants of streptococcal toxin a and methods of use

    Regents of the University of Minnesota · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  22. US 6632628

    Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

    The Board of Regents of the University of Texas System · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  23. US 6632437

    Immunogenic polysaccharide-protein conjugates containing poly &agr;(2→8), &agr;(2→9) NeuNAc capsular polysaccharides

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired
  24. AU 2003224729

    (+)-2-(1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL)-4-ACETYLAMINOISOINDOLINE-1,3-DIONE: METHODS OF USING AND COMPOSITIONS THEREOF

    CELGENE CORP [CH] · Granted Oct 8, 2003 · Expires Oct 3, 2023

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.